AHR and chronic myelogenous leukemia, BCR-ABL1 positive: These results have been shown in a large number of patients with CML at diagnosis, suggesting a major participation of this down-regulation to the myeloproliferative phenotype as this has been shown in AHR-/- mice [25] [26].